share_log

Ocuphire Pharma | 3: Initial statement of beneficial ownership of securities-Chief Operating Officer SCHACHLE JOSEPH K

SEC announcement ·  Nov 27, 2023 18:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more